Winklevoss’ Zcash company pivots to cancer drug after $37.8M loss
Unless the price of ZEC rallies, Cypherpunk Technologies says it will need to raise a lot of money to pay for its upcoming FDA trials.
Read more (3 min) →1 story, newest first
Unless the price of ZEC rallies, Cypherpunk Technologies says it will need to raise a lot of money to pay for its upcoming FDA trials.
Read more (3 min) →